Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-5-5
pubmed:abstractText
Although mesenchymal stem cells (MSCs) have therapeutic potential for tissue injury, intolerance and poor cell viability limit their reparative capability. Therefore, we examined the impact of bone marrow-derived MSCs, in which heme oxygenase-1 (HO-1) was transiently overexpressed, on the repair of an ischemic myocardial injury. When MSCs and HO-1-overexpressed MSCs (MSC(HO-1)) were exposed to serum deprivation/hypoxia or H(2)O(2)-induced oxidative stress, MSC(HO-1) exhibited increased resistance to cell apoptosis compared with MSCs (17 +/- 1 vs. 30 +/- 2%, P < 0.05) and were markedly resistant to cell death (2 +/- 1 vs. 32 +/- 2%, P < 0.05). Under these conditions, vascular endothelial growth factor (VEGF) production was 2.1-fold greater in MSC(HO-1) than in MSCs. Pretreatment of MSCs and MSC(HO-1) with phosphatidylinositol 3-kinase (PI 3-kinase)/protein kinase B (Akt) pathway inhibitors such as LY-294002 (50 muM) or wortmannin (100 nM) significantly decreased VEGF production. In a rat infarction model with MSCs or MSC(HO-1) (5 x 10(6) +/- 0.1 x 10(6) cells/rat) transplantation, the number of TdT-mediated dUTP nick end-labeling-positive cells was significantly lower in the MSC(HO-1) group than in the MSC group (12.1 +/- 1.0 cells/field vs. 26.5 +/- 2.6, P < 0.05) on the 4th day after cell transplantation. On the 28th day, increased capillary density associated with decreased infarction size was observed in the MSC(HO-1) group (1,415 +/- 47/mm(2) with 21.6 +/- 2.3%) compared with those in the MSCs group (1,215 +/- 43/mm(2) with 28.2 +/- 2.3%, P < 0.05), although infarction size relative to area at risk was not different in each group at 24 h after transplantation. These results demonstrate that MSC(HO-1) exhibit markedly enhanced anti-apoptotic and anti-oxidative capabilities compared with MSCs, thus contributing to improved repair of ischemic myocardial injury through cell survival and VEGF production associated with the PI 3-kinase/Akt pathway.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1522-1539
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
298
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
H1320-9
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:20154257-Animals, pubmed-meshheading:20154257-Apoptosis, pubmed-meshheading:20154257-Bone Marrow Transplantation, pubmed-meshheading:20154257-Capillaries, pubmed-meshheading:20154257-Cell Differentiation, pubmed-meshheading:20154257-Cell Lineage, pubmed-meshheading:20154257-Cell Survival, pubmed-meshheading:20154257-Culture Media, Serum-Free, pubmed-meshheading:20154257-Cytokines, pubmed-meshheading:20154257-Heme Oxygenase-1, pubmed-meshheading:20154257-Male, pubmed-meshheading:20154257-Mesenchymal Stem Cell Transplantation, pubmed-meshheading:20154257-Myocardial Ischemia, pubmed-meshheading:20154257-Oxidative Stress, pubmed-meshheading:20154257-Phenotype, pubmed-meshheading:20154257-Phosphatidylinositol 3-Kinases, pubmed-meshheading:20154257-Proto-Oncogene Proteins c-akt, pubmed-meshheading:20154257-RNA, pubmed-meshheading:20154257-Rats, pubmed-meshheading:20154257-Rats, Inbred Lew, pubmed-meshheading:20154257-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20154257-Vascular Endothelial Growth Factor A
pubmed:year
2010
pubmed:articleTitle
Impact of anti-apoptotic and anti-oxidative effects of bone marrow mesenchymal stem cells with transient overexpression of heme oxygenase-1 on myocardial ischemia.
pubmed:affiliation
Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medicine, Takara-machi 13-1, Kanazawa, Ishikawa, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't